Scientific Programme
18th june 2010
  New perspectives of radiotherapy
Chair: Lori J. Pierce
Rapporteur: Roberta Lazzari
08:15 Progress in external radiation therapy: accelerated and partial breast irradiation - Frank A. Vicini
08:35 Intraoperative radiotherapy – Roberto Orecchia
08:50 Potential role for proton therapy in the treatment of breast cancer - Alphonse G. Taghian
09:05 Metabolic radionuclide therapy to the breast: the avidin-biotin IART® approach - Giovanni Paganelli
09:20 Discussion
09:35 Spotlight:
Tissue-specific metastases: is selective targeting of therapies possible?
Roger Gomis
  Endocrine treatment
Chair: Eric P. Winer
Rapporteur: Emilia Montagna
10:00 Endocrine therapies for premenopausal women: new aspects? – Rosalba Torrisi
10:15 Endocrine therapies for postmenopausal women: defining the best available? – Eric P. Winer
10:30 Coffee break
11:00 Endocrine therapies revisited: using old dogs for new tricks – Alan S. Coates
11:15 Discussion
11:30 Spotlight:
Antiangiogenesis revised for breast cancer
Harold J. Burstein
11:50 The Milan Breast Cancer Observatory: Innovation and care in the next 12 months
Participants: Alan S. Coates, Viviana Galimberti, Aron Goldhirsch, Roberto Orecchia, Virgilio Sacchini, Eric P. Winer, Fatima Cardoso
Chair: Alberto Costa
12:50 Lunch
  Targeted treatments
Chair: Martine Piccart-Gebhart
Rapporteur: Angela Esposito
14:00 Targeting cellular pathways in breast cancer: an overview – Michele De Laurentiis
14:20 Useful therapeutic targeting for triple negative breast cancer – Giuseppe Curigliano
14:35 Useful therapeutic targeting for “luminal B” breast cancer – Phuong Dinh
14:50 Discussion
15.00 Spotlight:
Preoperative systemic treatments: is there a state of the art?
Gunter von Minckwitz
15:20 Coffee break
  Chemotherapy & angiogenesis
Chair: Marco Colleoni
Rapporteur: Marzia Locatelli
15:45 Antiangiogenesis: new approaches, new opportunities and new risks – Francesco Bertolini
16:05 Cytotoxics for breast cancer: are there new drugs which are useful? – Fatima Cardoso
16:25 Discussion
16:45 Closing remarks